# A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

> **NCT00332748** · PHASE1 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 36 (—)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Oral Taxane

## Key facts

- **NCT ID:** NCT00332748
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** 36 (—)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332748, "A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00332748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*